相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Symptom Clusters in Patients With Advanced Cancer: A Reanalysis Comparing Different Statistical Methods
Emily Chen et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2012)
Multiple Loci Modulate Opioid Therapy Response for Cancer Pain
Antonella Galvan et al.
CLINICAL CANCER RESEARCH (2011)
Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioids
Eiuor A. Laugsand et al.
EUROPEAN JOURNAL OF CANCER (2011)
Which variables are associated with pain intensity and treatment response in advanced cancer patients? - Implications for a future classification system for cancer pain
Anne Kari Knudsen et al.
EUROPEAN JOURNAL OF PAIN (2011)
Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients
P. Klepstad et al.
PAIN (2011)
Opioid switching and rotation in primary care: implementation and clinical utility
Neal E. Slatkin
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Expansion of the human μ-opioid receptor gene architecture: novel functional variants
Svetlana A. Shabalina et al.
HUMAN MOLECULAR GENETICS (2009)
Frequency, Indications, Outcomes, and Predictive Factors of Opioid Switching in an Acute Palliative Care Unit
Sebastiano Mercadante et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Multivariate Methods to Identify Cancer-Related Symptom Clusters
Helen M. Skerman et al.
RESEARCH IN NURSING & HEALTH (2009)
Assessment and classification of cancer pain
Marianne J Hjermstad et al.
Current Opinion in Supportive and Palliative Care (2009)
COPD phenotype description using principal components analysis
Kay Roy et al.
RESPIRATORY RESEARCH (2009)
Morphine and propranolol co-administration impair consolidation of Y-maze spatial recognition memory
Jie Zhang et al.
BRAIN RESEARCH (2008)
Genetic variation and response to morphine in cancer patients - Catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects
Joy R. Ross et al.
CANCER (2008)
Genetic variation in the Catechol-O-Methyltransferase (COMT) gene and morphine requirements in cancer patients with pain
Trude T. Rakvag et al.
MOLECULAR PAIN (2008)
Principle components analysis of pain thresholds to thermal, electrical, and mechanical stimuli suggests a predominant common source of variance
Till J. Neddermeyer et al.
PAIN (2008)
Genetic variability of the μ-opioid receptor influences intrathecal fentanyl analgesia requirements in laboring women
Ruth Landau et al.
PAIN (2008)
Pain assessment tools in palliative care: an urgent need for consensus
M. J. Hjermstad et al.
PALLIATIVE MEDICINE (2008)
Cell surface targeting of μ-δ opioid receptor heterodirners by RTP4
Fabien M. Decaillot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Candidate gene polymorphisms predicting individual sensitivity to opioids
Shinya Kasai et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief
D. Campa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Genetic architecture of human pain perception
Luda Diatchenko et al.
TRENDS IN GENETICS (2007)
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain:: OPRM1 and COMT gene
Cielito C. Reyes-Gibby et al.
PAIN (2007)
Replicating genotype-phenotype associations
Stephen J. Chanock et al.
NATURE (2007)
β1 Adrenergic receptors in the bed nucleus of stria terminalis mediate differential responses to opiate withdrawal
Marco Cecchi et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations
Dennis C. Turk et al.
PAIN (2006)
A genetic association study of the functional A118G polymorphism of the human μ-opioid receptor gene in patients with acute and chronic pain
Piotr K. Janicki et al.
ANESTHESIA AND ANALGESIA (2006)
Association of μ-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty
W. -Y. Chou et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2006)
Human opioid receptor A118G polymorphlism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy
Wen-Ying Chou et al.
ANESTHESIOLOGY (2006)
Environmental and genetic factors associated with morphine response in the postoperative period
L Coulbault et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients
J Riley et al.
SUPPORTIVE CARE IN CANCER (2006)
Opioid analgesia in persons at risk for hypertension
JA McCubbin et al.
PSYCHOSOMATIC MEDICINE (2006)
The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients
TT Rakvåg et al.
PAIN (2005)
Polymorphism of μ-opioid receptor gene (OPRM1:c.118A >G) does not protect against opioid-induced respiratory depression despite reduced analgesic response
RR Romberg et al.
ANESTHESIOLOGY (2005)
Genome-wide association studies: Theoretical and practical concerns
WYS Wang et al.
NATURE REVIEWS GENETICS (2005)
Genome-wide association studies for common diseases and complex traits
JN Hirschhorn et al.
NATURE REVIEWS GENETICS (2005)
A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
I Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Functional interaction among opioid receptor types:: up-regulation of μ- and δ-opioid receptor functions after repeated stimulation of κ-opioid receptors
J Khotib et al.
NEUROPHARMACOLOGY (2004)
The 118 A > G polymorphism in the human μ-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease
P Klepstad et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2004)
A retrospective study of the association between haematological and biochemical parameters and morphine intolerance in patients with cancer pain
J Riley et al.
PALLIATIVE MEDICINE (2004)
Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor
A Beyer et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients
M Holthe et al.
PHARMACOGENOMICS JOURNAL (2003)
The Norwegian Brief Pain Inventory questionnaire: Translation and validation in cancer pain patients
P Klepstad et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2002)
Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy
M Holthe et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Attenuated cross talk between κ-opioid receptors and β-adrenoceptors in the heart of chronically hypoxic rats
J Shan et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2002)
The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine
J Lotsch et al.
PHARMACOGENETICS (2002)
Strategies to manage the adverse effects of oral morphine: An evidence-based report
N Cherny et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
